Digital Health Technology England Approves Joenja for Ultra-Rare Disease While EU Review ContinuesMarch 13, 2025 Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.
Digital Health Technology Ex-NICE Official: Advanced Therapies for Common Conditions in England Won’t Get Extra FundingFebruary 28, 2025 A former senior figure at England’s NICE states that advanced therapies for common conditions would not qualify for the usual payment modifiers.
